Gefitinib from China
Gefitinib is an EGFR tyrosine kinase inhibitor for lung cancer treatment. This 4-anilinoquinazoline (aromatic N-heterocycle) is classified as a bulk pharmaceutical drug under HTS 2933.99.75.00.
Duty Rate — China → United States
6.5%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Ensure entry includes FDA Drug Establishment Registration number
• Test for genotoxic impurities per ICH M7 guidelines before import
• Avoid bulk packaging over 25kg drums which trigger additional hazmat documentation